
BPSR
Biotechnology · Healthcare · $66.1M market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Jul 31, 2021 | Time not confirmed | — | -0.00 | — |
| Apr 30, 2021 | Time not confirmed | — | -0.00 | — |
| Jan 31, 2021 | Time not confirmed | — | -0.01 | — |
| Oct 31, 2020 | Time not confirmed | — | -0.01 | — |
| Jul 31, 2020 | Time not confirmed | — | -0.01 | — |
| Apr 30, 2020 | Time not confirmed | 0.00 | -0.00 | — |
| Jan 31, 2020 | Time not confirmed | — | -0.00 | — |
| Oct 31, 2019 | Time not confirmed | — | -0.00 | — |
| Jul 31, 2019 | Time not confirmed | — | -0.00 | — |
| Apr 30, 2019 | Time not confirmed | — | -0.00 | — |
| Jan 31, 2019 | Time not confirmed | — | -0.00 | — |
| Oct 31, 2018 | Time not confirmed | — | -0.00 | — |
| Jul 31, 2018 | Time not confirmed | — | -0.00 | — |
Organicell Regenerative Medicine, Inc., a clinical-stage biopharmaceutical company, focuses on the development of biological therapeutics for the treatment of degenerative diseases. Its leading product candidate is Zofin, an acellular, biologic therapeutic derived from perinatal sources and is manufactured to retain naturally occurring microRNAs without the addition or combination of any other substance or diluent,…
| Apr 30, 2018 |
| Time not confirmed |
| — |
| -0.02 |
| — |
| Jan 31, 2018 | Time not confirmed | — | -0.00 | — |